Preclinical Implications for Existing, and New Circulatory Assist Devices
The National Center for Biotechnology Information describes mechanical circulatory assist devices as, “commonly used in the treatment of severe heart failure as bridges to cardiac transplant, as destination therapy for patients who are not transplant candidates, and as bridges to recovery and “decision-making.” These devices, which can be used to support the left or right…